To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MYL9TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
514 supporting clones for gene MYL9 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG988583 head_neck -u 1 to 432 1 to 433   tiling clone,   433/434
(99 %)
14 diff
(96.8 %id)
AW946253 lung_tumor -u 21 to 292 274 to 2   tiling clone, Submitted on the opposite strand 273/404
(67 %)
0 diff
(100 %id)
BG992806 head_neck -u 80 to 523 453 to 11   tiling clone,   443/453
(97 %)
0 diff
(100 %id)
DB284215 uterus -u 356 to 767 136 to 547   tiling clone, capped   412/546
(75 %)
6 diff
(99.0 %id)
AW291920   -u 549 to 818 287 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 270/270
(100 %)
0 diff
(100 %id)
CN266015 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells -u 587 to 1077 1 to 492   tiling clone,   492/492
(100 %)
5 diff
(99.0 %id)
AL702632 human skeletal muscle -u 686 to 1291 1 to 606   tiling clone,   606/606
(100 %)
18 diff
(97.1 %id)
DB268989 uterus -u 961 to 1529 2 to 570   tiling clone, capped   569/570
(99 %)
9 diff
(98.5 %id)
TI_57182332   -u 999 to 1868 97 to 955       859/956
(89 %)
7 diff
(99.3 %id)
BI771971 pooled lung and spleen -u 1001 to 1868 1 to 858   tiling clone,   858/859
(99 %)
30 diff
(96.6 %id)
BQ925748 sciatic nerve -u 1193 to 2067 1 to 883       883/886
(99 %)
14 diff
(98.5 %id)
CD358127 testis -u 1418 to 2138 1 to 724   tiling clone,   724/877
(82 %)
6 diff
(99.4 %id)
BM820953 stomach -u 1780 to 2362 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BM849018 stomach -u 1780 to 2242 1 to 463       463/463
(100 %)
1 diff
(99.8 %id)
BM849074 stomach -u 1780 to 2363 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BF376702 testis_normal -u 1850 to 2078 234 to 6       229/245
(93 %)
0 diff
(100 %id)
AW834839 leiomios -u 1958 to 2576 617 to 1   tiling clone,   617/618
(99 %)
8 diff
(98.8 %id)
BP330823 rectum MYL9.b 1 to 584 1 to 582 N3T G4A P5Q G6A L7G ... tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
TI_57217719   MYL9.c 1 to 678 33 to 710 K192* tiling clone,   678/710
(95 %)
8 diff
(98.9 %id)
TI_57201953   MYL9.c 41 to 669 53 to 707       655/707
(92 %)
35 diff
(95.1 %id)
BE836122 prostate_normal MYL9.c 79 to 692 616 to 4 P5Q D6R E7K D8I R10G ...     613/623
(98 %)
8 diff
(98.8 %id)
AJ710041 heart MYL9.c 495 to 933 64 to 501       438/501
(87 %)
6 diff
(98.9 %id)
BG952710 colon MYL9.c 495 to 676 211 to 30       182/215
(84 %)
0 diff
(100 %id)
TI_149288376   MYL9.c 495 to 1245 824 to 80   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 745/958
(77 %)
8 diff
(99.2 %id)
TI_154045052   MYL9.c 495 to 1245 833 to 85   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 749/950
(78 %)
9 diff
(99.1 %id)
TI_154128156   MYL9.c 495 to 1245 845 to 89   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 757/976
(77 %)
27 diff
(97.3 %id)
TI_151735057   MYL9.c 500 to 1245 813 to 69   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 745/798
(93 %)
5 diff
(99.4 %id)
BX436946 thymus MYL9.c 501 to 1044 759 to 212       548/759
(72 %)
0 diff
(100 %id)
TI_154098064   MYL9.c 501 to 1245 837 to 98   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 740/1097
(67 %)
8 diff
(99.3 %id)
TI_154127508   MYL9.c 501 to 1245 828 to 85   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 744/970
(76 %)
4 diff
(99.6 %id)
TI_159689876   MYL9.c 501 to 1245 883 to 146   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 738/973
(75 %)
19 diff
(98.1 %id)
TI_151706315   MYL9.c 501 to 1245 842 to 101   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 742/936
(79 %)
8 diff
(99.2 %id)
TI_149310473   MYL9.c 503 to 1245 828 to 85   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 744/933
(79 %)
8 diff
(99.2 %id)
AA335448 epididymis MYL9.c 506 to 813 1 to 308       308/313
(98 %)
2 diff
(99.4 %id)
TI_149281969   MYL9.c 531 to 1243 802 to 89       714/804
(88 %)
0 diff
(100 %id)
BM971378 lung MYL9.c 532 to 1245 735 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 717/717
(100 %)
5 diff
(99.4 %id)
CA419254 Bone, Human Chondrosarcoma Cell Line MYL9.c 532 to 1245 731 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 713/713
(100 %)
2 diff
(99.8 %id)
TI_149283900   MYL9.c 534 to 1243 794 to 86       709/794
(89 %)
0 diff
(100 %id)
BU628731 Bone, Enchondroma cell line MYL9.c 534 to 1245 729 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 711/711
(100 %)
1 diff
(99.9 %id)
ES312516 frontal balding hair, skin MYL9.c 537 to 696 1 to 159       159/163
(97 %)
8 diff
(95.1 %id)
TI_149284872   MYL9.c 537 to 1245 791 to 83   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 709/710
(99 %)
3 diff
(99.6 %id)
BU616030 Bone, Subchondral Bone MYL9.c 537 to 1245 727 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 709/709
(100 %)
0 diff
(100 %id)
AA318181 retina MYL9.c 541 to 832 1 to 292       292/292
(100 %)
0 diff
(100 %id)
R86086 breast MYL9.c 541 to 877 1 to 341       341/400
(85 %)
8 diff
(98.0 %id)
BU631774 cell lines, Chondrosarcoma MYL9.c 542 to 1247 723 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 705/705
(100 %)
1 diff
(99.9 %id)
CX753817 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass MYL9.c 551 to 1248 1 to 698     Submitted on the opposite strand 698/733
(95 %)
2 diff
(99.8 %id)
AA335067 esophagus MYL9.c 552 to 832 1 to 281       281/281
(100 %)
0 diff
(100 %id)
CF127333 Chondrosarcoma Lung Metastasis cell lines, lung MYL9.c 552 to 1092 1 to 542       542/542
(100 %)
1 diff
(99.9 %id)
TI_154190889   MYL9.c 552 to 1245 51 to 745   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 695/695
(100 %)
1 diff
(99.9 %id)
AA295810 Pancreas MYL9.c 556 to 840 1 to 285       285/285
(100 %)
0 diff
(100 %id)
AA345884 gall bladder MYL9.c 556 to 841 1 to 287       287/291
(98 %)
2 diff
(99.4 %id)
BM669129 eye, lens MYL9.c 557 to 1245 707 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 689/689
(100 %)
0 diff
(100 %id)
H44263 breast MYL9.c 567 to 1000 1 to 448   fully sequenced,   448/448
(100 %)
31 diff
(93.1 %id)
H45733 breast MYL9.c 567 to 877 1 to 312       312/492
(63 %)
7 diff
(98.6 %id)
TI_154018476   MYL9.c 567 to 1245 790 to 99   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 692/708
(97 %)
18 diff
(97.5 %id)
AA335775 epididymis MYL9.c 573 to 830 1 to 258       258/258
(100 %)
0 diff
(100 %id)
AA336121 epididymis MYL9.c 573 to 807 1 to 235       235/237
(99 %)
1 diff
(99.6 %id)
H44495 breast MYL9.c 573 to 877 1 to 309       309/372
(83 %)
8 diff
(97.9 %id)
BQ019979 Chondrosarcoma, Left Pubic Bone MYL9.c 573 to 1247 695 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 677/677
(100 %)
3 diff
(99.6 %id)
W23514 lung MYL9.c 575 to 803 1 to 230       230/230
(100 %)
9 diff
(96.1 %id)
R62381 placenta MYL9.c 576 to 891 1 to 317       317/317
(100 %)
3 diff
(99.1 %id)
H78905.
matches multiple genes
liver and spleen MYL9.c 576 to 848 1 to 274     also hits gene TRAK1 274/274
(100 %)
4 diff
(98.6 %id)
BM686883 eye, eye anterior segment MYL9.c 577 to 891 9 to 323   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 315/323
(97 %)
0 diff
(100 %id)
AW970526   MYL9.c 579 to 1097 1 to 520       520/527
(98 %)
9 diff
(98.3 %id)
BM685579 eye, RPE and Choroid MYL9.c 582 to 1245 1 to 665   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 665/665
(100 %)
5 diff
(99.3 %id)
BP421649 small intestine MYL9.c 583 to 1117 1 to 536     Submitted on the opposite strand 536/536
(100 %)
1 diff
(99.9 %id)
BM994937 Chondrosarcoma, Left Pubic Bone MYL9.c 583 to 1245 681 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 663/663
(100 %)
1 diff
(99.9 %id)
BQ006710 Chondrosarcoma, Left Pelvis MYL9.c 591 to 1245 671 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 653/653
(100 %)
2 diff
(99.7 %id)
ES314593 occipital scalp hair, skin MYL9.c 597 to 736 1 to 139       139/139
(100 %)
4 diff
(97.2 %id)
AA225596   MYL9.c 597 to 986 1 to 389       389/390
(99 %)
7 diff
(98.3 %id)
C03257 heart MYL9.c 599 to 1065 1 to 479       479/479
(100 %)
22 diff
(95.5 %id)
BP426179 small intestine MYL9.c 600 to 693 7 to 100     Submitted on the opposite strand 94/100
(94 %)
6 diff
(94.0 %id)
BU627211 Bone, Enchondroma cell line MYL9.c 604 to 1245 660 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 642/642
(100 %)
0 diff
(100 %id)
R49761 breast MYL9.c 607 to 964 1 to 374   fully sequenced,   374/374
(100 %)
28 diff
(92.6 %id)
BM691347 eye, RPE and Choroid MYL9.c 608 to 1171 1 to 564       564/564
(100 %)
6 diff
(99.0 %id)
AL048329 uterus MYL9.c 620 to 1152 537 to 1       537/538
(99 %)
15 diff
(97.3 %id)
BU681353 lung MYL9.c 620 to 1245 644 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 626/626
(100 %)
0 diff
(100 %id)
BQ435210 leiomyosarcoma, uterus MYL9.c 623 to 1245 1 to 623       623/651
(95 %)
1 diff
(99.9 %id)
BU617880 Bone, Subchondral Bone MYL9.c 625 to 1245 639 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 621/635
(97 %)
0 diff
(100 %id)
AA375158 lung MYL9.c 629 to 879 1 to 251       251/310
(80 %)
4 diff
(98.8 %id)
BM984286 lung MYL9.c 630 to 1243 635 to 21       615/637
(96 %)
0 diff
(100 %id)
C04607 heart MYL9.c 632 to 982 1 to 350       350/350
(100 %)
7 diff
(98.0 %id)
C03171 heart MYL9.c 643 to 872 1 to 230       230/230
(100 %)
2 diff
(99.2 %id)
AA295869 trachea MYL9.c 655 to 947 1 to 293       293/293
(100 %)
0 diff
(100 %id)
CA440956 Chondrosarcoma, Left Pubic Bone MYL9.c 656 to 1245 608 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 590/590
(100 %)
0 diff
(100 %id)
CN372399 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYL9.c 682 to 994 1 to 313       313/313
(100 %)
4 diff
(98.8 %id)
AW068546 Bone, Hip MYL9.c 684 to 1226 554 to 9       546/559
(97 %)
0 diff
(100 %id)
BP425900 small intestine MYL9.c 685 to 803 1 to 119     Submitted on the opposite strand 119/119
(100 %)
5 diff
(95.8 %id)
H85249 melanocyte MYL9.c 697 to 784 1 to 88       88/88
(100 %)
1 diff
(98.9 %id)
BG926320 cartilage MYL9.c 706 to 1076 77 to 448       372/378
(98 %)
6 diff
(98.5 %id)
DR156216 human embryonic stem cells differentiated toan early endodermal cell type MYL9.c 708 to 1245 563 to 26   AAA Submitted on the opposite strand 538/538
(100 %)
4 diff
(99.3 %id)
BE774333 uterus MYL9.c 712 to 928 24 to 239       216/239
(90 %)
6 diff
(97.5 %id)
AA884775 pooled MYL9.c 713 to 1141 426 to 1       426/426
(100 %)
34 diff
(92.1 %id)
AA946613 2 pooled tumors (clear cell type), Kidney MYL9.c 714 to 1141 426 to 1       426/432
(98 %)
17 diff
(96.1 %id)
BE774366 uterus MYL9.c 717 to 949 17 to 248       232/249
(93 %)
12 diff
(95.2 %id)
BE774174 uterus MYL9.c 720 to 928 207 to 1       207/207
(100 %)
2 diff
(99.1 %id)
BM695749 eye, optic nerve MYL9.c 721 to 1245 10 to 534   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 525/534
(98 %)
6 diff
(98.9 %id)
BE925298 amnion_normal MYL9.c 722 to 966 253 to 13       241/253
(95 %)
0 diff
(100 %id)
BE925314 amnion_normal MYL9.c 723 to 985 293 to 32       262/293
(89 %)
0 diff
(100 %id)
ES315017 occipital scalp hair, skin MYL9.c 724 to 929 1 to 206       206/206
(100 %)
3 diff
(98.6 %id)
BQ945586 epidermoid carcinoma, cell line, lung MYL9.c 727 to 1246 561 to 35   AAA Submitted on the opposite strand 527/936
(56 %)
38 diff
(96.0 %id)
AI970677 normal prostate, Prostate MYL9.c 730 to 994 265 to 1       265/265
(100 %)
19 diff
(92.9 %id)
TI_154101954   MYL9.c 736 to 1245 606 to 94   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 513/889
(57 %)
54 diff
(94.0 %id)
AW800813 uterus MYL9.c 740 to 1115 9 to 382       374/393
(95 %)
6 diff
(98.5 %id)
AA599342 bone marrow stroma MYL9.c 744 to 1141 397 to 1       397/397
(100 %)
18 diff
(95.5 %id)
BP388616 pancreatic islet MYL9.c 745 to 1245 1 to 502     Submitted on the opposite strand 502/503
(99 %)
2 diff
(99.7 %id)
BP392583 pancreatic islet MYL9.c 749 to 1245 1 to 498     Submitted on the opposite strand 498/498
(100 %)
1 diff
(99.8 %id)
R83680 breast MYL9.c 749 to 872 1 to 124   fully sequenced,   124/124
(100 %)
2 diff
(98.4 %id)
AA600270 bone marrow stroma MYL9.c 749 to 1245 497 to 1       497/497
(100 %)
5 diff
(99.0 %id)
AW793757 uterus MYL9.c 750 to 906 157 to 2       156/187
(83 %)
0 diff
(100 %id)
AI284586 ovary, tumor, 5 pooled (see description) MYL9.c 751 to 1245 487 to 1       487/491
(99 %)
10 diff
(98.0 %id)
AW057855 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MYL9.c 751 to 1228 474 to 1       474/478
(99 %)
10 diff
(98.0 %id)
AA335524 epididymis MYL9.c 753 to 1052 1 to 301       301/304
(99 %)
2 diff
(99.4 %id)
AA834008 Kidney, kidney tumor MYL9.c 754 to 1245 490 to 1       490/490
(100 %)
8 diff
(98.4 %id)
AW843934 colon_normal MYL9.c 756 to 927 185 to 14       172/185
(92 %)
0 diff
(100 %id)
AA652181 normal prostate, Prostate MYL9.c 756 to 1141 377 to 1       377/377
(100 %)
32 diff
(91.6 %id)
AJ707873 heart MYL9.c 758 to 1242 14 to 498       485/498
(97 %)
6 diff
(98.8 %id)
N88644   MYL9.c 758 to 917 1 to 160       160/160
(100 %)
10 diff
(93.8 %id)
TI_157615372   MYL9.c 759 to 1251 598 to 107       492/598
(82 %)
0 diff
(100 %id)
BP393687 pancreatic islet MYL9.c 764 to 1243 1 to 480     Submitted on the opposite strand 480/480
(100 %)
0 diff
(100 %id)
BE771975 prostate_tumor MYL9.c 766 to 1197 440 to 10       431/440
(97 %)
0 diff
(100 %id)
AI536883 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MYL9.c 766 to 1020 263 to 8       256/300
(85 %)
0 diff
(100 %id)
AA336217 epididymis MYL9.c 768 to 1129 1 to 361       361/364
(99 %)
8 diff
(97.9 %id)
AW878414 ovary MYL9.c 775 to 1016 1 to 242       242/242
(100 %)
0 diff
(100 %id)
BF055306 pooled MYL9.c 779 to 1244 466 to 1       466/466
(100 %)
0 diff
(100 %id)
DB574185 hypothalamus MYL9.c 786 to 1245 1 to 460     Submitted on the opposite strand 460/460
(100 %)
1 diff
(99.8 %id)
AI304521 adenocarcinoma, colon MYL9.c 791 to 1245 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AA534237 invasive prostate tumor, Prostate MYL9.c 797 to 1246 468 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 450/463
(97 %)
16 diff
(96.6 %id)
BM821825 stomach MYL9.c 797 to 1074 1 to 278       278/278
(100 %)
3 diff
(99.0 %id)
CV353775 stomach_normal MYL9.c 798 to 1006 1 to 213       213/213
(100 %)
18 diff
(91.6 %id)
C04176 heart MYL9.c 802 to 1116 1 to 318       318/318
(100 %)
9 diff
(97.2 %id)
AI092314 heart MYL9.c 802 to 1141 340 to 1       340/340
(100 %)
18 diff
(94.8 %id)
BF374132 stomach_normal MYL9.c 807 to 1118 328 to 13       316/328
(96 %)
0 diff
(100 %id)
AI280662 ovary, tumor, 5 pooled (see description) MYL9.c 807 to 1245 436 to 1       436/436
(100 %)
12 diff
(97.3 %id)
AI086832 senescent fibroblast MYL9.c 812 to 1245 454 to 21   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 434/434
(100 %)
0 diff
(100 %id)
BE938422 testis_normal MYL9.c 824 to 1196 374 to 3       372/378
(98 %)
0 diff
(100 %id)
CR738597 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MYL9.c 825 to 1244 435 to 16   AAA Submitted on the opposite strand 420/421
(99 %)
5 diff
(98.9 %id)
H21752 breast MYL9.c 828 to 953 1 to 126       126/131
(96 %)
1 diff
(99.3 %id)
AA259219   MYL9.c 829 to 1245 427 to 10       418/427
(97 %)
0 diff
(100 %id)
BE843841 testis_normal MYL9.c 830 to 1126 474 to 177       298/474
(62 %)
0 diff
(100 %id)
BE938445 testis_normal MYL9.c 830 to 1205 377 to 1       377/386
(97 %)
6 diff
(98.5 %id)
BE938518 testis_normal MYL9.c 830 to 1126 425 to 128       298/425
(70 %)
0 diff
(100 %id)
BP425784 small intestine MYL9.c 839 to 1017 1 to 181     Submitted on the opposite strand 181/181
(100 %)
5 diff
(97.3 %id)
R83681 breast MYL9.c 842 to 1153 313 to 1   fully sequenced,   313/313
(100 %)
7 diff
(97.8 %id)
AA781200   MYL9.c 847 to 1141 295 to 1       295/295
(100 %)
14 diff
(95.3 %id)
AI125356   MYL9.c 847 to 1246 415 to 16   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 400/400
(100 %)
0 diff
(100 %id)
AA887389 carcinoid, lung MYL9.c 853 to 1141 289 to 1       289/289
(100 %)
8 diff
(97.3 %id)
AA316985 lung MYL9.c 861 to 1126 1 to 266       266/266
(100 %)
0 diff
(100 %id)
BM673712 eye, eye anterior segment MYL9.c 861 to 1245 404 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 386/386
(100 %)
0 diff
(100 %id)
H44592 breast MYL9.c 863 to 954 92 to 1   fully sequenced,   92/92
(100 %)
3 diff
(96.8 %id)
AA578385 bone marrow, stem cells MYL9.c 863 to 1143 9 to 289       281/289
(97 %)
6 diff
(98.0 %id)
AA327303 colon MYL9.c 866 to 1067 1 to 202       202/202
(100 %)
0 diff
(100 %id)
BI488417 brain MYL9.c 873 to 1245 1 to 373   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 373/373
(100 %)
0 diff
(100 %id)
TI_45378828   MYL9.c 873 to 1245 61 to 433   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 373/433
(86 %)
6 diff
(98.7 %id)
R48906 breast MYL9.c 881 to 958 1 to 78       78/78
(100 %)
0 diff
(100 %id)
AA541749 normal prostate, Prostate MYL9.c 882 to 1141 260 to 1       260/260
(100 %)
9 diff
(96.6 %id)
H44452 breast MYL9.c 890 to 1221 341 to 1       341/341
(100 %)
9 diff
(97.4 %id)
CB050702 Prostate MYL9.c 890 to 1247 384 to 27   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 358/358
(100 %)
0 diff
(100 %id)
AA427777 ovarian tumor, ovary MYL9.c 900 to 1247 352 to 1       352/352
(100 %)
15 diff
(95.8 %id)
BF092131 testis_normal MYL9.c 901 to 1086 1 to 189       189/228
(82 %)
13 diff
(94.3 %id)
R62382 placenta MYL9.c 902 to 955 54 to 1       54/54
(100 %)
4 diff
(92.6 %id)
N86740   MYL9.c 903 to 1117 1 to 213       213/213
(100 %)
9 diff
(95.8 %id)
BU735029 eye, lens MYL9.c 912 to 1245 353 to 20   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 334/334
(100 %)
2 diff
(99.5 %id)
BP394065 pancreatic islet MYL9.c 915 to 1192 1 to 278     Submitted on the opposite strand 278/278
(100 %)
0 diff
(100 %id)
AA225661   MYL9.c 915 to 1141 232 to 1       232/232
(100 %)
6 diff
(97.5 %id)
CN372343 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYL9.c 916 to 1191 276 to 1     Submitted on the opposite strand 276/276
(100 %)
5 diff
(98.2 %id)
AA369171 placenta MYL9.c 917 to 1071 1 to 155       155/155
(100 %)
0 diff
(100 %id)
CR603140 placenta MYL9.c 918 to 1245 1 to 328       328/328
(100 %)
0 diff
(100 %id)
R49976 breast MYL9.c 924 to 1188 326 to 60       267/326
(81 %)
0 diff
(100 %id)
AW069352 bone marrow stroma MYL9.c 926 to 1245 345 to 26   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 320/320
(100 %)
0 diff
(100 %id)
C75396   MYL9.c 928 to 1245 326 to 9       318/326
(97 %)
0 diff
(100 %id)
CN372378 embryonic stem cells, cell lines H1, H7, andH9 MYL9.c 931 to 1168 238 to 1     Submitted on the opposite strand 238/238
(100 %)
4 diff
(98.4 %id)
AI921658 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MYL9.c 932 to 1142 205 to 1       205/211
(97 %)
16 diff
(92.5 %id)
BG117157 adenocarcinoma, cell line, Liver MYL9.c 933 to 1245 1 to 313   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 313/313
(100 %)
0 diff
(100 %id)
AW881492 ovary MYL9.c 939 to 1067 134 to 7       128/135
(94 %)
0 diff
(100 %id)
BQ030426 lung, Metastatic Chondrosarcoma MYL9.c 943 to 1245 321 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 303/303
(100 %)
0 diff
(100 %id)
AI084528   MYL9.c 944 to 1069 126 to 1       126/126
(100 %)
0 diff
(100 %id)
AA853433 Bone, Hip MYL9.c 946 to 1241 303 to 8       296/303
(97 %)
0 diff
(100 %id)
R49807 breast MYL9.c 950 to 1242 306 to 7   fully sequenced,   300/306
(98 %)
0 diff
(100 %id)
AW068126 Bone, Hip MYL9.c 951 to 1236 294 to 9       286/294
(97 %)
0 diff
(100 %id)
AA348877 adrenal gland MYL9.c 955 to 1245 291 to 1       291/291
(100 %)
0 diff
(100 %id)
AI832920 colon MYL9.c 964 to 1141 178 to 1       178/178
(100 %)
6 diff
(96.7 %id)
AA991358 breast MYL9.c 966 to 1079 114 to 1       114/114
(100 %)
3 diff
(97.4 %id)
CA946296 eye, lacrimal gland MYL9.c 970 to 1095 126 to 1     Submitted on the opposite strand 126/126
(100 %)
0 diff
(100 %id)
AW016211   MYL9.c 982 to 1245 281 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 264/264
(100 %)
0 diff
(100 %id)
AA335076 esophagus MYL9.c 987 to 1245 259 to 1       259/259
(100 %)
0 diff
(100 %id)
H45687 breast MYL9.c 1001 to 1230 230 to 1       230/230
(100 %)
2 diff
(99.2 %id)
R85299 liver and spleen MYL9.c 1001 to 1065 65 to 1       65/65
(100 %)
0 diff
(100 %id)
AI719561 colon MYL9.c 1008 to 1245 238 to 1       238/238
(100 %)
0 diff
(100 %id)
AA335847 epididymis MYL9.c 1022 to 1245 1 to 224       224/224
(100 %)
0 diff
(100 %id)
N84919   MYL9.c 1023 to 1121 15 to 116       102/116
(87 %)
6 diff
(94.9 %id)
AA443896 ovarian tumor, ovary MYL9.c 1031 to 1141 111 to 1       111/111
(100 %)
0 diff
(100 %id)
AA852586 Bone, Hip MYL9.c 1032 to 1246 216 to 2       215/216
(99 %)
0 diff
(100 %id)
AA369051 placenta MYL9.c 1044 to 1245 1 to 202       202/202
(100 %)
0 diff
(100 %id)
AW962633   MYL9.c 1045 to 1247 1 to 203   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 203/203
(100 %)
0 diff
(100 %id)
H84919 melanocyte MYL9.c 1066 to 1118 53 to 1       53/53
(100 %)
2 diff
(96.3 %id)
AW796683 uterus MYL9.c 1085 to 1243 172 to 14       159/172
(92 %)
0 diff
(100 %id)
ES314013 occipital scalp hair, skin MYL9.c 1087 to 1245 173 to 18   AAA Submitted on the opposite strand 156/156
(100 %)
2 diff
(98.8 %id)
AA565008 normal prostate, Prostate MYL9.c 1094 to 1245 182 to 31   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 152/152
(100 %)
0 diff
(100 %id)
AI804673 Prostate MYL9.c 1115 to 1245 131 to 1       131/131
(100 %)
0 diff
(100 %id)
AI804694 Prostate MYL9.c 1115 to 1245 131 to 1       131/131
(100 %)
0 diff
(100 %id)
AA652190 normal prostate, Prostate MYL9.c 1116 to 1245 130 to 1       130/130
(100 %)
0 diff
(100 %id)
AA531258 normal prostate, Prostate MYL9.c 1122 to 1247 126 to 1       126/126
(100 %)
0 diff
(100 %id)
AA868646   MYL9.c 1140 to 1190 51 to 1       51/51
(100 %)
0 diff
(100 %id)
AW085887 esophagus, squamous cell carcinoma MYL9.c 1155 to 1245 112 to 22   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 91/95
(95 %)
3 diff
(96.9 %id)
AI751847 Bone, Hip MYL9.c 1216 to 1528 1 to 313   tiling clone,   313/313
(100 %)
3 diff
(99.1 %id)
AL697699 human skeletal muscle MYL9.d 1 to 496 1 to 496   tiling clone,   496/496
(100 %)
1 diff
(99.8 %id)
BQ953325 eye, normal pigmented retinal epithelium MYL9.d 11 to 763 1 to 768 exact     768/986
(77 %)
16 diff
(98.4 %id)
NM_006097.3   MYL9.d 11 to 1197 1 to 1187 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1187/1187
(100 %)
0 diff
(100 %id)
BQ887528 carcinoma, cell line, Prostate MYL9.d 16 to 788 1 to 789 M74I S75E E76R A77G P80A ...     789/946
(83 %)
22 diff
(97.7 %id)
BQ947527 carcinoma, cell line, Prostate MYL9.d 16 to 752 1 to 748 exact     748/990
(75 %)
19 diff
(98.1 %id)
C05277 heart MYL9.d 17 to 333 1 to 317       317/317
(100 %)
0 diff
(100 %id)
BP231914 muscle MYL9.d 18 to 599 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM551051 duodenal adenocarcinoma, cell line, small intestine MYL9.d 20 to 681 1 to 667 exact     667/1263
(52 %)
7 diff
(99.5 %id)
CN372340 embryonic stem cells, cell lines H1, H7, andH9 MYL9.d 21 to 431 1 to 411       411/411
(100 %)
0 diff
(100 %id)
CN482060 eye MYL9.d 21 to 615 1 to 595       595/595
(100 %)
0 diff
(100 %id)
TI_57172376   MYL9.d 21 to 624 25 to 631 F90Y E100D D101G V102C I103D ...     607/635
(95 %)
20 diff
(96.9 %id)
BF724175 eye, Iris MYL9.d 22 to 499 1 to 478       478/478
(100 %)
0 diff
(100 %id)
BQ640165 eye, retina MYL9.d 22 to 611 1 to 590       590/590
(100 %)
0 diff
(100 %id)
CN372352 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.d 24 to 528 1 to 505       505/505
(100 %)
0 diff
(100 %id)
BX359913 Placenta Cot 25-normalized MYL9.d 24 to 931 1 to 896 E141Z D171X D172X     896/905
(99 %)
29 diff
(96.8 %id)
BQ067448 pooled brain, lung, testis MYL9.d 27 to 965 10 to 964 D172E     955/1065
(89 %)
48 diff
(95.5 %id)
BP373370 umbilical cord MYL9.d 27 to 607 1 to 581       581/581
(100 %)
0 diff
(100 %id)
TI_57170971   MYL9.d 28 to 644 31 to 647 exact     617/648
(95 %)
15 diff
(97.7 %id)
BU855006 ovary, teratocarcinoma, cell line MYL9.d 31 to 861 40 to 891 D171T     852/993
(85 %)
38 diff
(96.2 %id)
D82057   MYL9.d 33 to 1195 1 to 1164 exact tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1164/1164
(100 %)
2 diff
(99.9 %id)
TI_57227982   MYL9.d 35 to 644 57 to 669 exact     613/614
(99 %)
7 diff
(98.9 %id)
CB143006 Liver MYL9.d 35 to 617 1 to 583       583/583
(100 %)
0 diff
(100 %id)
AK130879 umbilical cord MYL9.d 36 to 1195 1 to 1160 exact tiling clone, available from FLJ,   1160/1160
(100 %)
0 diff
(100 %id)
BQ712260 Spleen MYL9.d 36 to 946 1 to 913 D171T     913/915
(99 %)
16 diff
(98.3 %id)
BU553229 ovary, teratocarcinoma, cell line MYL9.d 36 to 763 1 to 735 exact     735/995
(73 %)
11 diff
(98.9 %id)
DA008380 adipose MYL9.d 37 to 597 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA270951 caudate nucleus MYL9.d 37 to 611 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA477195   MYL9.d 37 to 604 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA575295   MYL9.d 37 to 589 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB283026 uterus MYL9.d 37 to 564 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
ES309518 occipital hair of pubic hypotrichosispatient, skin MYL9.d 42 to 436 23 to 410       388/560
(69 %)
11 diff
(98.1 %id)
CD514788 White Matter MYL9.d 42 to 897 1 to 862 exact     862/863
(99 %)
8 diff
(99.1 %id)
BM839777 myeloma MYL9.d 42 to 604 1 to 563       563/563
(100 %)
0 diff
(100 %id)
CA406020 adipose MYL9.d 43 to 666 1 to 623 exact     623/623
(100 %)
1 diff
(99.9 %id)
BU528176 epidermoid carcinoma, cell line, lung MYL9.d 43 to 923 1 to 913 exact     913/926
(98 %)
42 diff
(95.5 %id)
TI_154193529   MYL9.d 43 to 896 51 to 884 D172T     834/997
(83 %)
23 diff
(97.7 %id)
TI_57166576   MYL9.d 44 to 645 36 to 638 R144P E145R A146G P147T I148H ...     603/640
(94 %)
14 diff
(97.9 %id)
CB138440 Liver MYL9.d 44 to 617 1 to 574       574/574
(100 %)
0 diff
(100 %id)
TI_154194234   MYL9.d 44 to 773 39 to 763 exact     725/1062
(68 %)
20 diff
(98.2 %id)
TI_57149875   MYL9.d 45 to 630 1 to 586 S2C S3G F26L D27T Q28S ...     586/587
(99 %)
12 diff
(98.0 %id)
ES310079 scalp interfollicular dermis, skin MYL9.d 46 to 373 1 to 332       332/341
(97 %)
6 diff
(98.3 %id)
BP327870 prostata MYL9.d 46 to 627 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
BF724279 eye, Iris MYL9.d 47 to 330 1 to 284       284/284
(100 %)
0 diff
(100 %id)
DR158595 human embryonic stem cells differentiated toan early endodermal cell type MYL9.d 47 to 807 1 to 761 exact     761/761
(100 %)
4 diff
(99.5 %id)
TI_57198270   MYL9.d 47 to 630 64 to 646 F26L D27T Q28S S29P Q30R ...     583/646
(90 %)
8 diff
(98.8 %id)
TI_43963811   MYL9.d 47 to 671 73 to 709 M142H Y143V R144P E145G A146G ...     637/860
(74 %)
33 diff
(96.2 %id)
TI_57176129   MYL9.d 47 to 631 60 to 644 exact     585/659
(88 %)
8 diff
(98.8 %id)
CD245523 White Matter MYL9.d 48 to 869 20 to 849 exact     830/906
(91 %)
19 diff
(98.0 %id)
TI_57197146   MYL9.d 48 to 647 25 to 624 exact     600/651
(92 %)
11 diff
(98.4 %id)
ES310431 scalp interfollicular dermis, skin MYL9.d 49 to 622 1 to 571       571/668
(85 %)
8 diff
(98.9 %id)
TI_154189464   MYL9.d 49 to 890 51 to 887 exact     837/1005
(83 %)
10 diff
(99.1 %id)
BM560366 brain, medulla MYL9.d 50 to 1076 21 to 1067 D171T     1047/1074
(97 %)
50 diff
(95.4 %id)
TI_57170194   MYL9.d 50 to 631 65 to 648 K150N K151E G152R N153Q F154L ...     584/751
(77 %)
10 diff
(98.7 %id)
TI_57164853   MYL9.d 50 to 690 29 to 676 M40T I41D D42* AAA   648/844
(76 %)
76 diff
(91.0 %id)
TI_57167492   MYL9.d 50 to 633 72 to 655 exact AAA   584/676
(86 %)
8 diff
(98.9 %id)
BF725072 eye, Iris MYL9.d 51 to 400 1 to 350       350/350
(100 %)
0 diff
(100 %id)
CF127915 Chondrosarcoma Lung Metastasis cell lines, lung MYL9.d 51 to 617 1 to 567       567/567
(100 %)
0 diff
(100 %id)
TI_43963736   MYL9.d 51 to 596 31 to 578   fully sequenced,   548/578
(94 %)
7 diff
(98.8 %id)
DA899058 skeletal muscle MYL9.d 51 to 589 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
TI_154190279   MYL9.d 51 to 972 50 to 967 D171A D172Q     918/922
(99 %)
6 diff
(99.4 %id)
TI_154193606   MYL9.d 51 to 862 51 to 848 D172T     798/987
(80 %)
7 diff
(99.3 %id)
BM919327 pooled pancreas and spleen MYL9.d 52 to 869 1 to 833 exact     833/1072
(77 %)
23 diff
(97.9 %id)
BU145977 dorsal root ganglia MYL9.d 52 to 969 1 to 925 D171T     925/926
(99 %)
12 diff
(98.8 %id)
CF127152 Chondrosarcoma Lung Metastasis cell lines, lung MYL9.d 52 to 613 1 to 562       562/562
(100 %)
0 diff
(100 %id)
TI_57172767   MYL9.d 52 to 624 74 to 648 K4E K170*     575/757
(75 %)
13 diff
(98.3 %id)
TI_57168644   MYL9.d 52 to 633 68 to 653 F26L D27T Q28S S29P Q30R ...     586/807
(72 %)
15 diff
(98.2 %id)
BM698523 eye, fetal eyes MYL9.d 52 to 432 1 to 380     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 380/380
(100 %)
1 diff
(99.8 %id)
CN372362 embryonic stem cells, DMSO-treated H9 cellline MYL9.d 53 to 493 1 to 441       441/441
(100 %)
0 diff
(100 %id)
AL047279 uterus MYL9.d 53 to 609 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DB502993 hypothalamus MYL9.d 53 to 527 1 to 474       474/474
(100 %)
2 diff
(99.6 %id)
TI_57165882   MYL9.d 53 to 632 26 to 605 exact     580/619
(93 %)
7 diff
(98.9 %id)
TI_57166709   MYL9.d 53 to 638 26 to 611 exact     586/616
(95 %)
8 diff
(98.8 %id)
AA853432 Bone, Hip MYL9.d 53 to 357 1 to 305       305/305
(100 %)
7 diff
(97.8 %id)
BP425029 small intestine MYL9.d 54 to 550 1 to 497     Submitted on the opposite strand 497/497
(100 %)
0 diff
(100 %id)
BU854786 ovary, teratocarcinoma, cell line MYL9.d 54 to 876 1 to 833 exact     833/945
(88 %)
20 diff
(97.9 %id)
CX166777 human embryonic stem cells differentiated toan early endodermal cell type MYL9.d 54 to 839 1 to 786 exact     786/786
(100 %)
0 diff
(100 %id)
CN372338 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.d 55 to 613 1 to 559       559/559
(100 %)
0 diff
(100 %id)
CA390499 eye, RPE/choroid MYL9.d 55 to 617 1 to 563       563/563
(100 %)
0 diff
(100 %id)
ES309315 occipital hair of pubic hypotrichosispatient, skin MYL9.d 55 to 752 28 to 728 K170X     701/728
(96 %)
10 diff
(98.7 %id)
ES310444 scalp interfollicular dermis, skin MYL9.d 55 to 753 1 to 702 K7N A8P K9Q T10D T11H ...     702/723
(97 %)
13 diff
(98.3 %id)
BQ277629 ovary, teratocarcinoma, cell line MYL9.d 55 to 776 1 to 726 exact     726/1090
(66 %)
12 diff
(98.9 %id)
DB255565 uterus MYL9.d 55 to 639 2 to 586 exact capped   585/585
(100 %)
0 diff
(100 %id)
BF724751 eye, Iris MYL9.d 56 to 621 1 to 566       566/566
(100 %)
0 diff
(100 %id)
CN372354 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.d 58 to 607 1 to 550       550/550
(100 %)
0 diff
(100 %id)
BM685664 eye, RPE and Choroid MYL9.d 58 to 600 1 to 542     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 542/542
(100 %)
4 diff
(99.3 %id)
CA395863 eye, RPE/choroid MYL9.d 59 to 600 1 to 542       542/542
(100 %)
0 diff
(100 %id)
BM919331 pooled pancreas and spleen MYL9.d 59 to 965 1 to 918 D171T D172X     918/1008
(91 %)
27 diff
(97.4 %id)
BQ959370 leiomyosarcoma, uterus MYL9.d 59 to 896 1 to 858 exact     858/903
(95 %)
30 diff
(96.7 %id)
BU542869 carcinoma, cell line, Prostate MYL9.d 59 to 914 1 to 868 exact     868/874
(99 %)
15 diff
(98.3 %id)
BF725062 eye, Iris MYL9.d 61 to 577 1 to 517       517/517
(100 %)
0 diff
(100 %id)
BF725585 eye, Iris MYL9.d 61 to 578 1 to 518       518/518
(100 %)
0 diff
(100 %id)
BF725870 eye, Iris MYL9.d 61 to 588 1 to 528       528/528
(100 %)
0 diff
(100 %id)
CN372345 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.d 61 to 607 8 to 554       547/554
(98 %)
6 diff
(99.0 %id)
CN372392 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.d 61 to 614 9 to 562       554/562
(98 %)
6 diff
(99.0 %id)
CA394322 eye, RPE/choroid MYL9.d 61 to 698 1 to 638 exact     638/638
(100 %)
1 diff
(99.9 %id)
CN482238 eye MYL9.d 61 to 615 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BM800385 leiomyosarcoma, uterus MYL9.d 61 to 1001 49 to 997 exact     949/1045
(90 %)
34 diff
(96.8 %id)
BM554527 brain, medulla MYL9.d 61 to 1003 1 to 955 D171T     955/1054
(90 %)
26 diff
(97.6 %id)
BM563352 brain, medulla MYL9.d 61 to 1013 1 to 964 D171R D172N     964/1071
(90 %)
6 diff
(99.5 %id)
TI_43961622   MYL9.d 61 to 646 91 to 678 A6X A8P K9R T10P T11P ...     588/734
(80 %)
23 diff
(96.9 %id)
TI_57198515   MYL9.d 61 to 636 36 to 611 exact     576/627
(91 %)
9 diff
(98.6 %id)
TI_57146302   MYL9.d 61 to 637 69 to 646 T97A     578/687
(84 %)
13 diff
(98.2 %id)
TI_57147482   MYL9.d 61 to 499 36 to 480       445/480
(92 %)
14 diff
(97.1 %id)
TI_57147958   MYL9.d 61 to 631 71 to 641 G47D     571/645
(88 %)
10 diff
(98.5 %id)
TI_57163989   MYL9.d 61 to 633 31 to 601 S2V     571/602
(94 %)
11 diff
(98.2 %id)
TI_57165143   MYL9.d 61 to 568 77 to 583       507/741
(68 %)
12 diff
(98.4 %id)
TI_154193519   MYL9.d 61 to 853 47 to 832 exact     786/989
(79 %)
14 diff
(98.6 %id)
CN372332 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.d 62 to 612 1 to 551       551/551
(100 %)
0 diff
(100 %id)
CD245763 White Matter MYL9.d 62 to 823 1 to 777 K168Q     777/905
(85 %)
31 diff
(96.6 %id)
CF127834 Chondrosarcoma Lung Metastasis cell lines, lung MYL9.d 62 to 618 1 to 557       557/557
(100 %)
0 diff
(100 %id)
CA396705 eye, RPE/choroid MYL9.d 63 to 546 1 to 484       484/484
(100 %)
0 diff
(100 %id)
CN482084 eye MYL9.d 63 to 615 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BQ953647 sciatic nerve MYL9.d 63 to 931 1 to 876 T66I D171T     876/886
(98 %)
24 diff
(97.3 %id)
BP420695 small intestine MYL9.d 64 to 567 1 to 504     Submitted on the opposite strand 504/504
(100 %)
0 diff
(100 %id)
BQ706812 Spleen MYL9.d 64 to 949 1 to 891 exact     891/937
(95 %)
21 diff
(97.8 %id)
BU856506 ovary, teratocarcinoma, cell line MYL9.d 64 to 964 1 to 909 D171T     909/909
(100 %)
22 diff
(97.6 %id)
AF176042   MYL9.d 65 to 1195 1 to 1132 I81Y A114S     1132/1133
(99 %)
6 diff
(99.5 %id)
CD621943   MYL9.d 66 to 623 1 to 558 exact     558/558
(100 %)
0 diff
(100 %id)
CD621945   MYL9.d 66 to 618 1 to 553       553/553
(100 %)
0 diff
(100 %id)
CD621947   MYL9.d 66 to 800 750 to 10 S2P T10D T11H K12Q K13E ...     741/750
(98 %)
4 diff
(99.5 %id)
CF130893 Chondrosarcoma Lung Metastasis cell lines, lung MYL9.d 66 to 677 1 to 612 exact     612/612
(100 %)
0 diff
(100 %id)
TI_154189942   MYL9.d 66 to 636 51 to 622 K164I     572/1014
(56 %)
4 diff
(99.7 %id)
TI_154193331   MYL9.d 66 to 770 50 to 753 exact     704/1007
(69 %)
13 diff
(98.8 %id)
BE770158 prostate_tumor MYL9.d 71 to 642 596 to 24 K7I T11S A59G S60L L61A ...     573/599
(95 %)
11 diff
(98.2 %id)
CA393353 eye, RPE/choroid MYL9.d 72 to 606 1 to 535       535/535
(100 %)
0 diff
(100 %id)
BQ614634 insulinoma, Pancreas MYL9.d 72 to 620 1 to 549     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 549/549
(100 %)
6 diff
(99.0 %id)
CF126743 Chondrosarcoma Lung Metastasis cell lines, lung MYL9.d 72 to 636 1 to 565 exact     565/565
(100 %)
0 diff
(100 %id)
TI_154189787   MYL9.d 72 to 677 48 to 655 exact     608/1038
(58 %)
12 diff
(98.9 %id)
CD621940   MYL9.d 76 to 660 585 to 1 D172A     585/595
(98 %)
4 diff
(99.4 %id)
CR603972 adult brain MYL9.d 76 to 1081 1 to 1006 exact     1006/1006
(100 %)
0 diff
(100 %id)
CR608537 Placenta Cot 25-normalized MYL9.d 76 to 1139 1 to 1064 exact     1064/1064
(100 %)
0 diff
(100 %id)
CR622560 Placenta Cot 25-normalized MYL9.d 76 to 1143 1 to 1068 exact     1068/1068
(100 %)
0 diff
(100 %id)
AL544249 placenta, Placenta Cot 25-normalized MYL9.d 76 to 384 1 to 309   fully sequenced,   309/309
(100 %)
0 diff
(100 %id)
AL554014 placenta, Placenta Cot 25-normalized MYL9.d 76 to 385 1 to 310   fully sequenced,   310/310
(100 %)
0 diff
(100 %id)
CD518348 White Matter MYL9.d 76 to 882 20 to 829 exact     810/829
(97 %)
12 diff
(98.6 %id)
TI_57200942   MYL9.d 76 to 596 56 to 575       520/575
(90 %)
6 diff
(99.0 %id)
TI_57148197   MYL9.d 76 to 633 54 to 613 exact     560/621
(90 %)
9 diff
(98.6 %id)
TI_57180056   MYL9.d 76 to 664 45 to 634 exact     590/645
(91 %)
12 diff
(98.2 %id)
TI_57161970   MYL9.d 76 to 645 50 to 620 exact AAA   571/664
(85 %)
12 diff
(98.2 %id)
TI_57162804   MYL9.d 76 to 653 42 to 620 exact     579/665
(87 %)
15 diff
(97.8 %id)
TI_57167612   MYL9.d 76 to 642 89 to 657 exact     569/691
(82 %)
13 diff
(98.2 %id)
CD518048 White Matter MYL9.d 77 to 902 1 to 837 exact     837/838
(99 %)
13 diff
(98.5 %id)
CD559112 White Matter MYL9.d 77 to 782 1 to 715 exact     715/913
(78 %)
9 diff
(99.1 %id)
BE927420 colon MYL9.d 79 to 319 249 to 9       241/249
(96 %)
2 diff
(99.2 %id)
BP420308 small intestine MYL9.d 79 to 617 1 to 539     Submitted on the opposite strand 539/539
(100 %)
0 diff
(100 %id)
BP423632 small intestine MYL9.d 81 to 600 1 to 520     Submitted on the opposite strand 520/520
(100 %)
0 diff
(100 %id)
BQ717137 sympathetic trunk MYL9.d 81 to 832 1 to 762 exact     762/878
(86 %)
17 diff
(98.1 %id)
CN372346 embryonic stem cells, DMSO-treated H9 cellline MYL9.d 82 to 376 1 to 295       295/295
(100 %)
0 diff
(100 %id)
TI_151768691   MYL9.d 82 to 608 106 to 638       533/920
(57 %)
36 diff
(96.1 %id)
TI_57172099   MYL9.d 83 to 633 102 to 642 S2Q S3G K4G R5P A6S ...     541/780
(69 %)
18 diff
(97.7 %id)
CR602511 Placenta Cot 25-normalized MYL9.d 87 to 1121 1 to 1035 exact     1035/1035
(100 %)
0 diff
(100 %id)
BF688329 eye, normal pigmented retinal epithelium MYL9.d 88 to 642 1 to 553 K170Q fully sequenced,   553/553
(100 %)
4 diff
(99.3 %id)
CN484400 eye MYL9.d 94 to 615 1 to 522       522/522
(100 %)
0 diff
(100 %id)
TI_57151467   MYL9.d 95 to 636 28 to 568 I148M     541/573
(94 %)
9 diff
(98.5 %id)
CD172144 White Matter MYL9.d 97 to 949 1 to 860 exact     860/870
(98 %)
13 diff
(98.6 %id)
TI_57202420   MYL9.d 100 to 631 63 to 591 S2V A8P K9R T10P T11P ... AAA   529/706
(74 %)
10 diff
(98.6 %id)
CF126711 Chondrosarcoma Lung Metastasis cell lines, lung MYL9.d 103 to 878 1 to 775 exact     775/775
(100 %)
1 diff
(99.9 %id)
TI_154189848   MYL9.d 103 to 1001 48 to 934 exact     887/983
(90 %)
19 diff
(98.1 %id)
CR456843   MYL9.d 105 to 622 1 to 518       518/519
(99 %)
3 diff
(99.5 %id)
CN372327 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYL9.d 112 to 711 1 to 600       600/600
(100 %)
0 diff
(100 %id)
CN372389 embryonic stem cells, cell lines H1, H7, andH9 MYL9.d 114 to 616 1 to 503       503/503
(100 %)
0 diff
(100 %id)
ES315079 occipital scalp hair, skin MYL9.d 114 to 310 1 to 198       198/198
(100 %)
2 diff
(99.0 %id)
AW948989 prostate_tumor MYL9.d 115 to 586 472 to 1     Submitted on the opposite strand 472/478
(98 %)
0 diff
(100 %id)
BP421864 small intestine MYL9.d 117 to 623 1 to 507     Submitted on the opposite strand 507/507
(100 %)
0 diff
(100 %id)
CD621944   MYL9.d 118 to 800 692 to 8       685/692
(98 %)
0 diff
(100 %id)
BM709012 eye, RPE and Choroid MYL9.d 120 to 621 1 to 502       502/502
(100 %)
0 diff
(100 %id)
AW949131 prostate_tumor MYL9.d 121 to 447 1 to 327       327/327
(100 %)
0 diff
(100 %id)
BE834555 prostate_normal MYL9.d 121 to 591 485 to 13       473/485
(97 %)
7 diff
(98.6 %id)
BE834579 prostate_normal MYL9.d 121 to 571 466 to 14       453/466
(97 %)
9 diff
(98.1 %id)
BQ073426 epidermoid carcinoma, cell line, lung MYL9.d 131 to 990 1 to 865       865/980
(88 %)
21 diff
(97.9 %id)
CN372380 embryonic stem cells, cell lines H1, H7, andH9 MYL9.d 134 to 429 1 to 296       296/296
(100 %)
0 diff
(100 %id)
CN372361 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYL9.d 136 to 614 1 to 479       479/479
(100 %)
0 diff
(100 %id)
TI_154194442   MYL9.d 137 to 633 55 to 553       499/1085
(45 %)
48 diff
(95.6 %id)
CN372393 embryonic stem cells, cell lines H1, H7, andH9 MYL9.d 139 to 731 1 to 593       593/593
(100 %)
0 diff
(100 %id)
CN372385 embryonic stem cells, cell lines H1, H7, andH9 MYL9.d 142 to 399 1 to 258       258/258
(100 %)
0 diff
(100 %id)
ES309560 occipital hair of pubic hypotrichosispatient, skin MYL9.d 143 to 614 23 to 490       468/520
(90 %)
11 diff
(97.9 %id)
CN372375 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.d 144 to 613 1 to 470       470/470
(100 %)
0 diff
(100 %id)
BQ957417 carcinoma, cell line, Prostate MYL9.d 152 to 957 1 to 826       826/938
(88 %)
42 diff
(95.6 %id)
CN372357 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYL9.d 154 to 638 1 to 485       485/485
(100 %)
0 diff
(100 %id)
BM691280 eye, RPE and Choroid MYL9.d 155 to 614 6 to 464     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 459/471
(97 %)
9 diff
(98.1 %id)
CD621946   MYL9.d 158 to 800 655 to 8       648/655
(98 %)
0 diff
(100 %id)
CN372363 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYL9.d 163 to 693 1 to 531       531/531
(100 %)
0 diff
(100 %id)
CD621935   MYL9.d 169 to 828 675 to 16       660/675
(97 %)
0 diff
(100 %id)
AA578085 Prostate, prostatic intraepithelial neoplasia - highgrade MYL9.d 198 to 592 416 to 23       394/425
(92 %)
2 diff
(99.6 %id)
BF371983 prostate_tumor MYL9.d 201 to 399 200 to 1       200/200
(100 %)
2 diff
(99.0 %id)
ES315180 occipital scalp hair, skin MYL9.d 203 to 362 1 to 160       160/160
(100 %)
3 diff
(98.2 %id)
BF370336 prostate_normal MYL9.d 209 to 650 455 to 11       445/455
(97 %)
15 diff
(96.8 %id)
AA225779   MYL9.d 228 to 401 1 to 174       174/174
(100 %)
8 diff
(95.5 %id)
BU855977 ovary, teratocarcinoma, cell line MYL9.d 234 to 1113 1 to 904       904/966
(93 %)
32 diff
(96.7 %id)
AW949133 prostate_tumor MYL9.d 240 to 577 338 to 1     Submitted on the opposite strand 338/338
(100 %)
2 diff
(99.5 %id)
BF371990 prostate_tumor MYL9.d 241 to 586 349 to 1       349/349
(100 %)
5 diff
(98.6 %id)
BF725693 eye, Iris MYL9.d 248 to 731 1 to 484       484/484
(100 %)
0 diff
(100 %id)
AA421852 ovarian tumor, ovary MYL9.d 254 to 627 1 to 371       371/372
(99 %)
46 diff
(87.7 %id)
TI_154189971   MYL9.d 256 to 1050 49 to 832       784/984
(79 %)
14 diff
(98.6 %id)
CD621937   MYL9.d 257 to 1072 836 to 21       816/836
(97 %)
0 diff
(100 %id)
CN372365 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.d 258 to 631 1 to 374       374/374
(100 %)
0 diff
(100 %id)
BF371989 prostate_tumor MYL9.d 260 to 535 276 to 1       276/276
(100 %)
0 diff
(100 %id)
TI_154189721   MYL9.d 260 to 1138 49 to 920       872/921
(94 %)
16 diff
(98.3 %id)
CN372335 embryonic stem cells, DMSO-treated H9 cellline MYL9.d 263 to 440 1 to 178       178/178
(100 %)
0 diff
(100 %id)
BM710958 eye, fetal eyes MYL9.d 266 to 683 1 to 418     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 418/418
(100 %)
1 diff
(99.8 %id)
ES312108 frontal balding hair, skin MYL9.d 270 to 437 1 to 167       167/167
(100 %)
3 diff
(98.3 %id)
CD621942   MYL9.d 273 to 592 323 to 4       320/323
(99 %)
0 diff
(100 %id)
AW949086 prostate_tumor MYL9.d 288 to 587 302 to 3     Submitted on the opposite strand 300/310
(96 %)
0 diff
(100 %id)
TI_43961624   MYL9.d 288 to 1147 869 to 1       869/1093
(79 %)
58 diff
(94.7 %id)
C05039 heart MYL9.d 303 to 624 1 to 322       322/322
(100 %)
0 diff
(100 %id)
ES311744 frontal balding hair, skin MYL9.d 303 to 482 1 to 180       180/180
(100 %)
5 diff
(97.3 %id)
BM687553 eye, eye anterior segment MYL9.d 312 to 841 9 to 536   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 528/536
(98 %)
2 diff
(99.7 %id)
BM686299 eye, eye anterior segment MYL9.d 312 to 622 9 to 319     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 311/319
(97 %)
0 diff
(100 %id)
BM696386 eye, lens MYL9.d 324 to 892 1 to 569       569/569
(100 %)
0 diff
(100 %id)
TI_154047668   MYL9.d 326 to 1196 950 to 84   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 867/1017
(85 %)
19 diff
(98.2 %id)
BU527627 epidermoid carcinoma, cell line, lung MYL9.d 333 to 1195 902 to 21   AAA Submitted on the opposite strand 880/936
(94 %)
29 diff
(97.0 %id)
BM697285 eye, lens MYL9.d 333 to 863 1 to 531     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 531/534
(99 %)
1 diff
(99.9 %id)
C04952 heart MYL9.d 336 to 627 1 to 292       292/297
(98 %)
1 diff
(99.7 %id)
C05336 heart MYL9.d 336 to 614 1 to 279       279/279
(100 %)
0 diff
(100 %id)
R76321 breast MYL9.d 349 to 574 1 to 226       226/226
(100 %)
0 diff
(100 %id)
AL570439 placenta, Placenta Cot 25-normalized MYL9.d 354 to 1143 791 to 1   fully sequenced,   791/791
(100 %)
2 diff
(99.8 %id)
AL576856 placenta, Placenta Cot 25-normalized MYL9.d 354 to 1139 788 to 1   fully sequenced,   788/788
(100 %)
2 diff
(99.8 %id)
BM782951 stomach MYL9.d 358 to 957 1 to 600       600/600
(100 %)
0 diff
(100 %id)
TI_154109242   MYL9.d 368 to 1197 909 to 88   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 822/955
(86 %)
21 diff
(97.9 %id)
TI_154127366   MYL9.d 368 to 1193 901 to 85   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 817/988
(82 %)
21 diff
(97.9 %id)
AW843914 colon_normal MYL9.d 373 to 606 238 to 5       234/238
(98 %)
1 diff
(99.6 %id)
T20300   MYL9.d 375 to 623 250 to 1       250/256
(97 %)
11 diff
(95.8 %id)
C02957 heart MYL9.d 391 to 584 1 to 199       199/199
(100 %)
15 diff
(92.5 %id)
AA379391 skin MYL9.d 394 to 635 1 to 242       242/242
(100 %)
0 diff
(100 %id)
ES311944 frontal balding hair, skin MYL9.d 394 to 587 1 to 194       194/194
(100 %)
2 diff
(99.0 %id)
BM701565 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid MYL9.d 394 to 729 1 to 335   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 335/335
(100 %)
2 diff
(99.5 %id)
AI833019 colon MYL9.d 403 to 1195 794 to 4       791/798
(99 %)
7 diff
(99.2 %id)
TI_149304774   MYL9.d 405 to 1193 872 to 85   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 788/945
(83 %)
17 diff
(98.3 %id)
BE378533 endometrium, adenocarcinoma cell line, uterus MYL9.d 410 to 602 1 to 193       193/193
(100 %)
0 diff
(100 %id)
BE836135 prostate_normal MYL9.d 422 to 642 230 to 11       220/230
(95 %)
0 diff
(100 %id)
AI127173 heart MYL9.d 423 to 1195 773 to 1       773/773
(100 %)
16 diff
(98.0 %id)
AL047159 uterus MYL9.d 434 to 633 1 to 200       200/200
(100 %)
0 diff
(100 %id)
TI_43963737   MYL9.d 566 to 1117 559 to 1   fully sequenced,   559/559
(100 %)
12 diff
(97.9 %id)
BF689120 eye, normal pigmented retinal epithelium MYL9.d 612 to 1161 554 to 1   fully sequenced,   554/554
(100 %)
5 diff
(99.1 %id)
BM663119 eye, RPE and Choroid MYL9.d 621 to 1196 593 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 576/576
(100 %)
0 diff
(100 %id)
BU726464 eye, RPE and Choroid MYL9.d 632 to 1195 584 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 566/566
(100 %)
5 diff
(99.2 %id)
BQ614414 insulinoma, Pancreas MYL9.d 685 to 1195 524 to 14   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 511/511
(100 %)
0 diff
(100 %id)
AA411471 ovarian tumor, ovary MYL9.d 694 to 1091 397 to 1       397/397
(100 %)
10 diff
(97.5 %id)
BM674563 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid MYL9.d 699 to 1195 515 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 497/497
(100 %)
5 diff
(99.0 %id)
BM672701 eye, eye anterior segment MYL9.d 704 to 1195 510 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 492/492
(100 %)
1 diff
(99.8 %id)
BM667438 eye, fetal eyes MYL9.d 730 to 1195 484 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 466/466
(100 %)
2 diff
(99.6 %id)
R76322 breast MYL9.d 776 to 906 131 to 1       131/131
(100 %)
0 diff
(100 %id)
BU727826 eye, eye anterior segment MYL9.d 811 to 1194 403 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 384/384
(100 %)
3 diff
(99.3 %id)
BM666057 eye, fetal eyes MYL9.d 846 to 1195 369 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 351/351
(100 %)
5 diff
(98.6 %id)
BM667931 eye, lens MYL9.d 919 to 1195 295 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 277/277
(100 %)
0 diff
(100 %id)
NM_181526.1   MYL9.e 1 to 1025 1 to 1025 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1025/1025
(100 %)
0 diff
(100 %id)
BM048787 carcinoma, cell line, Prostate MYL9.e 4 to 478 1 to 474       474/698
(67 %)
6 diff
(99.2 %id)
BM048448 carcinoma, cell line, Prostate MYL9.e 4 to 474 1 to 473   tiling clone, AAA   473/482
(98 %)
11 diff
(97.8 %id)
BU542452 carcinoma, cell line, Prostate MYL9.e 6 to 851 1 to 854       854/916
(93 %)
10 diff
(99.0 %id)
AA373685 lung MYL9.e 7 to 260 1 to 254       254/254
(100 %)
1 diff
(99.7 %id)
C03577 heart MYL9.e 7 to 183 1 to 179       179/179
(100 %)
8 diff
(95.6 %id)
C05560 heart MYL9.e 7 to 276 1 to 270       270/270
(100 %)
2 diff
(99.3 %id)
BM560116 brain, medulla MYL9.e 23 to 760 13 to 761   AAA   749/1092
(68 %)
39 diff
(96.5 %id)
CB114182 Liver MYL9.e 26 to 525 1 to 500       500/500
(100 %)
1 diff
(99.8 %id)
BP375519 uterus MYL9.e 26 to 600 1 to 579       579/579
(100 %)
21 diff
(96.4 %id)
CN372379 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYL9.e 29 to 459 1 to 431       431/431
(100 %)
4 diff
(99.1 %id)
BM473095 leiomyosarcoma, uterus MYL9.e 31 to 585 31 to 594       564/1370
(41 %)
16 diff
(98.9 %id)
CF130830 Chondrosarcoma Lung Metastasis cell lines, lung MYL9.e 33 to 706 1 to 674       674/674
(100 %)
0 diff
(100 %id)
TI_154192961   MYL9.e 33 to 927 51 to 923       873/991
(88 %)
33 diff
(96.7 %id)
ES308454 beard hair, skin MYL9.e 36 to 207 1 to 172       172/172
(100 %)
0 diff
(100 %id)
BF229207 amnion_normal MYL9.e 37 to 250 225 to 12       214/249
(85 %)
1 diff
(99.6 %id)
ES308073 beard hair, skin MYL9.e 41 to 206 1 to 166       166/170
(97 %)
1 diff
(99.5 %id)
TI_154193865   MYL9.e 41 to 584 50 to 594       545/973
(56 %)
20 diff
(98.0 %id)
TI_154194585   MYL9.e 41 to 800 47 to 807       761/1049
(72 %)
19 diff
(98.2 %id)
TI_154194609   MYL9.e 41 to 569 47 to 575       529/981
(53 %)
13 diff
(98.7 %id)
CF128048 Chondrosarcoma Lung Metastasis cell lines, lung MYL9.e 42 to 514 1 to 473       473/475
(99 %)
3 diff
(99.4 %id)
CF131130 Chondrosarcoma Lung Metastasis cell lines, lung MYL9.e 42 to 713 1 to 671       671/671
(100 %)
3 diff
(99.6 %id)
CF131151 Chondrosarcoma Lung Metastasis cell lines, lung MYL9.e 42 to 532 1 to 491       491/491
(100 %)
4 diff
(99.2 %id)
AU107432   MYL9.e 42 to 91 1 to 50       50/50
(100 %)
0 diff
(100 %id)
CD621934   MYL9.e 43 to 207 1 to 164       164/181
(90 %)
5 diff
(97.3 %id)
ES312929 beard hair, skin MYL9.e 45 to 243 1 to 191       191/191
(100 %)
12 diff
(93.8 %id)
AA359682 lung MYL9.e 46 to 269 1 to 224       224/224
(100 %)
1 diff
(99.6 %id)
BQ227877 epithelioid carcinoma, Pancreas MYL9.e 47 to 831 1 to 798       798/834
(95 %)
22 diff
(97.4 %id)
CN372364 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.e 48 to 228 1 to 181       181/181
(100 %)
0 diff
(100 %id)
CD621933   MYL9.e 50 to 207 171 to 14       158/178
(88 %)
0 diff
(100 %id)
C04027 heart MYL9.e 51 to 458 1 to 408       408/408
(100 %)
1 diff
(99.8 %id)
C05623 heart MYL9.e 51 to 293 1 to 243       243/243
(100 %)
0 diff
(100 %id)
C05639 heart MYL9.e 51 to 441 1 to 391       391/402
(97 %)
1 diff
(99.8 %id)
CN372331 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.e 51 to 572 9 to 531       523/531
(98 %)
7 diff
(98.7 %id)
CN372349 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYL9.e 51 to 283 1 to 232       232/237
(97 %)
4 diff
(98.4 %id)
BC002648 Uterus, endometrium adenocarcinoma MYL9.e 52 to 1025 1 to 974   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 974/974
(100 %)
0 diff
(100 %id)
ES307683 beard hair, skin MYL9.e 53 to 269 1 to 218       218/218
(100 %)
1 diff
(99.6 %id)
AF176043   MYL9.e 55 to 1023 1 to 970       970/971
(99 %)
2 diff
(99.8 %id)
ES308298 beard hair, skin MYL9.e 55 to 245 1 to 191       191/191
(100 %)
0 diff
(100 %id)
BF326183 amnion_normal MYL9.e 61 to 251 19 to 210       192/210
(91 %)
6 diff
(97.2 %id)
ES314539 occipital scalp hair, skin MYL9.e 62 to 213 1 to 152       152/152
(100 %)
0 diff
(100 %id)
ES315224 occipital scalp hair, skin MYL9.e 64 to 283 1 to 220       220/222
(99 %)
4 diff
(98.2 %id)
BP420923 small intestine MYL9.e 64 to 255 1 to 193     Submitted on the opposite strand 193/193
(100 %)
3 diff
(98.5 %id)
C03269 heart MYL9.e 66 to 379 9 to 325       317/329
(96 %)
6 diff
(98.2 %id)
BE515089 endometrium, adenocarcinoma cell line, uterus MYL9.e 74 to 463 1 to 388       388/396
(97 %)
7 diff
(98.3 %id)
ES308443 beard hair, skin MYL9.e 90 to 247 1 to 158       158/158
(100 %)
1 diff
(99.4 %id)
BG122018 adenocarcinoma, cell line, Liver MYL9.e 90 to 466 1 to 379       379/1215
(31 %)
5 diff
(99.6 %id)
T12354   MYL9.e 111 to 251 1 to 144       144/145
(99 %)
16 diff
(89.0 %id)
BE768377 prostate_tumor MYL9.e 111 to 195 101 to 20       82/101
(81 %)
0 diff
(100 %id)
T12353   MYL9.e 116 to 263 175 to 28       148/175
(84 %)
0 diff
(100 %id)
AW949149 prostate_tumor MYL9.e 155 to 487 337 to 5     Submitted on the opposite strand 333/337
(98 %)
0 diff
(100 %id)
BF339625 brain, glioblastoma with EGFR amplification MYL9.e 190 to 423 1 to 234       234/321
(72 %)
1 diff
(99.7 %id)
BM686111 eye, RPE and Choroid MYL9.e 266 to 788 1 to 520       520/520
(100 %)
3 diff
(99.5 %id)
BM461995 leiomyosarcoma, uterus MYL9.f-u 1 to 788 1 to 795   tiling clone,   795/889
(89 %)
7 diff
(99.3 %id)
AW365043 denis_drash MYL9.f-u 483 to 833 351 to 1       351/351
(100 %)
3 diff
(99.2 %id)
AK130977 adrenal gland MYL9.f-u 532 to 1182 1 to 651 R77H tiling clone, available from FLJ,   651/651
(100 %)
1 diff
(99.9 %id)
BX090163 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MYL9.f-u 563 to 1050 1 to 488 R77H     488/488
(100 %)
1 diff
(99.8 %id)
AA864758 Kidney, kidney tumor MYL9.f-u 691 to 1182 492 to 1       492/494
(99 %)
2 diff
(99.6 %id)
AI079949 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MYL9.f-u 755 to 1182 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
AW026720 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MYL9.f-u 755 to 1177 423 to 1       423/423
(100 %)
1 diff
(99.8 %id)
CA414593 Chondrosarcoma Grade II, Left Pelvis MYL9.f-u 756 to 1182 445 to 19   AAA   427/427
(100 %)
1 diff
(99.8 %id)
AI751846 Bone, Hip MYL9.f-u 778 to 1172 395 to 1   tiling clone,   395/395
(100 %)
0 diff
(100 %id)
DB277773 uterus MYL9.g-u 1 to 452 2 to 453   capped   452/452
(100 %)
0 diff
(100 %id)
DB284551 uterus MYL9.g-u 1 to 510 2 to 511   tiling clone, capped   510/510
(100 %)
0 diff
(100 %id)
AK097235 Spleen MYL9.g-u 6 to 3977 1 to 3972 exact tiling clone, available from FLJ,   3972/3972
(100 %)
10 diff
(99.8 %id)
DB278880 uterus MYL9.g-u 6 to 456 2 to 463   capped   462/462
(100 %)
11 diff
(97.7 %id)
DA944216 Spleen MYL9.g-u 7 to 553 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
CN481224 eye MYL9.g-u 1542 to 2117 1 to 576       576/576
(100 %)
5 diff
(99.2 %id)
BF740340 bocio_tumor MYL9.g-u 1594 to 1911 325 to 9     Submitted on the opposite strand 317/325
(97 %)
0 diff
(100 %id)
BI016362 lung_tumor MYL9.g-u 1676 to 2197 532 to 11       522/533
(97 %)
0 diff
(100 %id)
BG006337 placenta_normal MYL9.g-u 2724 to 3327 611 to 12       600/611
(98 %)
0 diff
(100 %id)
AW394198 testis MYL9.g-u 3435 to 3695 257 to 1       257/271
(94 %)
17 diff
(93.8 %id)
DB333403 Spleen MYL9.g-u 3448 to 3977 530 to 1       530/530
(100 %)
7 diff
(98.7 %id)
BG984862 colon_normal MYL9.g-u 3537 to 3910 374 to 1   tiling clone,   374/374
(100 %)
2 diff
(99.5 %id)
BP198342 adrenal gland MYL9.h 1 to 579 2 to 582 exact tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
DA262362 caudate nucleus MYL9.h 1 to 541 2 to 542 F34L tiling clone, capped   541/541
(100 %)
1 diff
(99.9 %id)
CN372355 embryonic stem cells, DMSO-treated H9 cellline MYL9.h 11 to 467 1 to 457 exact     457/457
(100 %)
1 diff
(99.8 %id)
CN372383 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.h 11 to 386 1 to 376 exact     376/376
(100 %)
5 diff
(98.7 %id)
CN372396 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MYL9.h 194 to 328 1 to 135       135/135
(100 %)
0 diff
(100 %id)
DB287651 uterus MYL9.i 1 to 564 2 to 566 R14X P15A Q16T R17A A18G ... tiling clone, capped   565/565
(100 %)
8 diff
(98.6 %id)
DB286344 uterus MYL9.i 26 to 568 2 to 544 exact capped   543/543
(100 %)
10 diff
(98.2 %id)
DB288771 uterus MYL9.i 30 to 578 2 to 550 exact capped   549/551
(99 %)
12 diff
(97.9 %id)
BP293223 lung MYL9.i 35 to 616 1 to 582 exact tiling clone,   582/582
(100 %)
5 diff
(99.2 %id)
BP293494 lung MYL9.i 35 to 618 1 to 584 exact tiling clone,   584/587
(99 %)
4 diff
(99.4 %id)
BE973592 Prostate MYL9.i 44 to 614 1 to 567 exact tiling clone,   567/567
(100 %)
10 diff
(98.3 %id)
ES309490 occipital hair of pubic hypotrichosispatient, skin Gene MYL9, variant not shown         Suspected internal deletion, this clone was ignored    
J02854   Gene MYL9, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a-u, .b, .c, .d, .e, .f-u, .g-u, .h, .i Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI